Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review

References

• Garcia-Pagàn JC, Buscarini E, Janssen HL, et al. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64:179–202.
   PubMedGoogle Scholar
• Mohty M, Malard F, Abecassis M, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplant. 2015;50:781–789.
   PubMed Web of Science ®Google Scholar
• Schouten JNL, Garcia-Pagan JC, Valla DC, et al. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011;54:1071–1081.
   PubMed Web of Science ®Google Scholar
• DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002;22:027–042.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Fisher LB, Schoch HG, et al. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19:1171–1181.
   PubMed Web of Science ®Google Scholar
• Kumar S, DeLeve LD, Kamath PS, et al. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc. 2003;78:589–598.
   PubMed Web of Science ®Google Scholar
• Carreras E, Diaz-Beya M, Rosinol L, et al. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant. 2011;17:1713–1720.
   PubMed Web of Science ®Google Scholar
• Dalle J-H, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2015;22:400–409.
   PubMed Web of Science ®Google Scholar
• Mohty M, Malard F, Abecassis M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2016.
   Web of Science ®Google Scholar
• Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157–168.
   PubMed Web of Science ®Google Scholar
• Richardson PG, Riches ML, Kernan NA, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127:1656–1665.
   PubMed Web of Science ®Google Scholar
• Richardson PG, Smith AR, Triplett BM, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017;178:112–118.
   Google Scholar
• McDonald GB, Sharma P, Matthews DE, et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116–122.
   PubMed Web of Science ®Google Scholar
• Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778–783.
   PubMed Web of Science ®Google Scholar
• Corbacioglu S, Carreras E, Ansari M, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2017.
   Web of Science ®Google Scholar
• Toh HC, McAfee SL, Sackstein R, et al. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant. 1999;24:891–895.
   PubMed Web of Science ®Google Scholar
• Dignan FL, Wynn RF, Hadzic N, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444–457.
   PubMed Web of Science ®Google Scholar
• Volin L, Niittyvuopio R, Heiskanen J, et al. Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation. Bone Marrow Transplant. 2016;51:1633–1635.
   PubMed Web of Science ®Google Scholar
• Carreras E, Grañena A, Navasa M, et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol. 1993;66:77–80.
   PubMed Web of Science ®Google Scholar
• Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421–441.
   PubMed Web of Science ®Google Scholar
• Bosch J, Abraldes JG, Berzigotti A, et al. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:573–582.
   PubMed Web of Science ®Google Scholar
• de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
   PubMed Web of Science ®Google Scholar
• Kis B, Pamarthi V, Fan C-M, et al. Safety and utility of transjugular liver biopsy in hematopoietic stem cell transplant recipients. J Vasc Interv Radiol. 2013;24:85–89.
   PubMed Web of Science ®Google Scholar
• Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500.
   PubMed Web of Science ®Google Scholar
• Cholongitas E, Quaglia A, Samonakis D, et al. Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut. 2006;55:1789–1794.
   PubMed Web of Science ®Google Scholar
• Lebrec D, Nataf C, Bernuau J, et al. Transient intrahepatic portal hypertension. A Case Report. Digestion. 1981;21:140–142.
   PubMed Web of Science ®Google Scholar
• Carreras E, Grañena A, Navasa M, et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant. 1993;11:21–26.
   PubMed Web of Science ®Google Scholar
• Berzigotti A, Seijo S, Reverter E, et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141–155.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation. 1995;59:1015–1022.
   PubMed Web of Science ®Google Scholar
• Bearman SI, Anderson GL, Mori M, et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol. 1993;11:1729–1736.
   PubMed Web of Science ®Google Scholar
• Fried MW, Connaghan DG, Sharma S, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology. 1996;24:588–591.
   PubMed Web of Science ®Google Scholar
• Zenz T, Rossle M, Bertz H, et al. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation–role of transjugular intrahepatic portosystemic shunt (TIPS). Liver. 2001;21:31–36.
   PubMedGoogle Scholar
• Azoulay D, Castaing D, Lemoine A, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant. 2000;25:987–992.
   PubMed Web of Science ®Google Scholar
• Pelegrina A, Martí J, Miquel R, et al. Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”. World J Surg Oncol. 2017;15:224.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Trenker C, Fontanilla T, et al. New ultrasound techniques challenge the diagnosis of sinusoidal obstruction syndrome. Ultrasound Med Biol. 2018;44:2171-2182.
   Web of Science ®Google Scholar
• Matsuishi E, Anzai K, Dohmen K, et al. Sonographic diagnosis of venocclusive disease of the liver and danazol therapy for autoimmune thrombocytopenia in an autologous marrow transplant patient. Jpn J Clin Oncol. 1990;20:188–192.
   PubMed Web of Science ®Google Scholar
• Schiavetti A, Matrunola M, Varrasso G, et al. Ultrasound in the management of hepatic veno-occlusive disease in three children treated with dactinomycin and vincristine. Pediatr Hematol Oncol. 1996;13:521–529.
   PubMed Web of Science ®Google Scholar
• Nicolau C, Brú C, Carreras E, et al. Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver. J Ultrasound Med. 1993;12:437–440.
   PubMed Web of Science ®Google Scholar
• Brown BP, Abu-Yousef M, Farner R, et al. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease. AJR Am J Roentgenol. 1990;154:721–724.
   PubMed Web of Science ®Google Scholar
• Sonneveld P, Laméris JS, Cornelissen J, et al. Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for veno-occlusive disease following myeloablative treatment. Bone Marrow Transplant. 1998;21:731–734.
   PubMed Web of Science ®Google Scholar
• Herbetko J, Grigg AP, Buckley AR, et al. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography. Am J Roentgenol. 1992;158:1001–1005.
   PubMed Web of Science ®Google Scholar
• Hommeyer SC, Teefey SA, Jacobson AF, et al. Venocclusive disease of the liver: prospective study of US evaluation. Radiology. 1992;184:683–686.
   PubMed Web of Science ®Google Scholar
• Teefey SA, Brink JA, Borson RA, et al. Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. AJR Am J Roentgenol. 1995;164:1397–1401.
   PubMed Web of Science ®Google Scholar
• Lassau N, Leclère J, Auperin A, et al. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology. 1997;204:545–552.
   PubMed Web of Science ®Google Scholar
• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension–part 2–and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med. 2012 [cited 2012 Feb 11];33:1–8.
   PubMed Web of Science ®Google Scholar
• Lassau N, Auperin A, Leclere J, et al. Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease. Transplantation. 2002;74:60–66.
   PubMed Web of Science ®Google Scholar
• McCarville MB, Hoffer FA, Howard SC, et al. Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings. Pediatr Radiol. 2001;31:102–105.
   PubMed Web of Science ®Google Scholar
• Kaya N, Erbey F, Atay D, et al. The diagnostic value of hepatic arterial velocity in venoocclusive disease after pediatric hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2017;39:249-253.
   Web of Science ®Google Scholar
• Park JE, Choi YH, Cheon J-E, et al. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation. Eur Radiol. 2018.
   Web of Science ®Google Scholar
• Fontanilla T, Hernando CG, Claros JCV, et al. Acoustic radiation force impulse elastography and contrast-enhanced sonography of sinusoidal obstructive syndrome (Veno-occlusive Disease): preliminary results. J Ultrasound Med. 2011;30:1593–1598.
   PubMed Web of Science ®Google Scholar
• Nishida M, Kahata K, Hayase E, et al. Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018;24:1896-1900.
   Google Scholar
• Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 2017;38:e16–e47.
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph J-M, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713.
   PubMed Web of Science ®Google Scholar
• Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360–369.
   PubMed Web of Science ®Google Scholar
• Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52:206–210.
   PubMed Web of Science ®Google Scholar
• Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008;48:1718–1723.
   PubMed Web of Science ®Google Scholar
• Vizzutti F, Arena U, Rega L, et al. Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease. Liver Int. 2007;27:1379–1388.
   PubMed Web of Science ®Google Scholar
• Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67:399–411.
   PubMed Web of Science ®Google Scholar
• Augustin S, Pons M, Maurice JB, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;00:1–9.
   Google Scholar
• Colecchia A, Montrone L, Scaioli E, et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology. 2012;143:646–654.
   PubMed Web of Science ®Google Scholar
• Ravaioli F, Montagnani M, Lisotti A, et al. Noninvasive assessment of portal hypertension in advanced chronic liver disease: an update. Gastroenterol Res Pract. 2018;2018:1–11.
   Google Scholar
• Auberger J, Graziadei I, Clausen J, et al. Non-invasive transient elastography for the prediction of liver toxicity following hematopoietic SCT. Bone Marrow Transplant. 2013;48:159–160.
   PubMed Web of Science ®Google Scholar
• Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP.
   Google Scholar
• Karlas T, Weber J, Nehring C, et al. Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT. Bone Marrow Transplant. 2014;49:806–811.
   PubMed Web of Science ®Google Scholar
• NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 4.
   Google Scholar
• Park SH, Lee SS, Sung J-Y, et al. Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models. Eur Radiol. 2017;28:2096-2106.
   Web of Science ®Google Scholar
• Colecchia A, Marasco G, Ravaioli F, et al. Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT. Bone Marrow Transplant. 2016;1–4.
   Web of Science ®Google Scholar
• Reddivalla N, Robinson AL, Reid KJ, et al. Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant. Bone Marrow Transplant. 2018.
   PubMedGoogle Scholar
• Colecchia A, Ravaioli F, Sessa M, et al. Liver Stiffness Measurement allows to early diagnose VOD/SOS inadult patients who underwent Hemopoietic Stem Cell Transplantation: results from a monocentric prospective study. Biol Blood Marrow Transplant. 2019. In press. DOI:10.1016/j.bbmt.2019.01.019.
   Google Scholar
• Mahgerefteh SY, Sosna J, Bogot N, et al. Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology. 2011;258:660–671.
   PubMed Web of Science ®Google Scholar
• Erturk SM, Mortel KJ, Binkert CA, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. Am J Roentgenol. 2006;186:1497–1501.
   PubMed Web of Science ®Google Scholar
• Wu X-W, Wang W-Q, Liu B, et al. Hepatic veno-occlusive disease after taking gynura rhizome: the value of multidetector computed tomography in diagnosing the disease and evaluating the clinical therapeutic effect. Hepatol Res. 2012;42:304–309.
   PubMed Web of Science ®Google Scholar
• Shao H, Chen HZ, Zhu JS, et al. Computed tomography findings of hepatic veno-occlusive disease caused by Sedum aizoon with histopathological correlation. Brazilian J Med Biol Res = Rev Bras Pesqui Medicas E Biol. 2015;48:1145–1150.
   PubMed Web of Science ®Google Scholar
• Kan X, Ye J, Rong X, et al. Diagnostic performance of Contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep. 2016;6:37998.
   PubMed Web of Science ®Google Scholar
• Yang S, Wu J, Lei S. CT features of hepatic veno-occlusive disease. Acad Radiol. 2018;25:328-337.
   Web of Science ®Google Scholar
• Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2005;23:2038–2048.
   PubMed Web of Science ®Google Scholar
• Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg. 2006;202:199–200.
   PubMed Web of Science ®Google Scholar
• Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg. 2008;247:118–124.
   PubMed Web of Science ®Google Scholar
• Bethke A, Kühne K, Platzek I, et al. Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography. Cancer Imaging. 2011;11:91–99.
   PubMed Web of Science ®Google Scholar
• Han NY, Park BJ, Kim MJ, et al. Hepatic parenchymal heterogeneity on contrast-enhanced ct scans following oxaliplatin-based chemotherapy: natural history and association with clinical evidence of sinusoidal obstruction syndrome. Radiology. 2015;276:766–774.
   PubMed Web of Science ®Google Scholar
• Cayet S, Pasco J, Dujardin F, et al. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: radio-pathological correlation. Eur J Radiol. 2017;94:180–190.
   PubMed Web of Science ®Google Scholar
• Uchino K, Fujisawa M, Watanabe T, et al. Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report. Jpn J Clin Oncol. 2013;43:1034–1038.
   PubMed Web of Science ®Google Scholar
• Kawai T, Yamazaki S, Iwama A, et al. Focal sinusoidal obstruction syndrome caused by oxaliplatin-induced chemotherapy: a case report. Hepat Mon. 2016;16:e37572.
   PubMed Web of Science ®Google Scholar
• Arakawa Y, Shimada M, Utsunomya T, et al. Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res. 2013;43:685–689.
   PubMed Web of Science ®Google Scholar
• You SH, Park BJ, Kim YH. Hepatic lesions that mimic metastasis on radiological imaging during chemotherapy for gastrointestinal malignancy: recent updates. Korean J Radiol. 2017;413–426.
   PubMed Web of Science ®Google Scholar
• van Den Bosch MA, van Hoe L. MR imaging findings in two patients with hepatic veno-occlusive disease following bone marrow transplantation. Eur Radiol. 2000;10:1290–1293.
   PubMed Web of Science ®Google Scholar
• Mortele KJ, Van Vlierberghe H, Wiesner W, et al. Hepatic veno-occlusive disease: MRI findings. Abdom Imaging. 2002;27:523–526.
   PubMedGoogle Scholar
• Dumont C, Lambert M, Van Beers BE. MR imaging findings in a patient with hepatic veno-occlusive disease. Acta Gastroenterol Belg. 2004;67:236–238.
   PubMed Web of Science ®Google Scholar
• Zhou H, Wang Y-XJ, Lou H, et al. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 2014;15:218–225.
   PubMed Web of Science ®Google Scholar
• Li X, Yang X, Xu D, et al. Magnetic resonance imaging findings in patients with pyrrolizidine alkaloid–induced hepatic sinusoidal obstruction syndrome. Clin Gastroenterol Hepatol. 2017;15:955–957.
   PubMed Web of Science ®Google Scholar
• Ward J, Guthrie JA, Sheridan MB, et al. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol. 2008;26:4304–4310.
   PubMed Web of Science ®Google Scholar
• Shin N-Y, Kim M-J, Lim JS, et al. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol. 2012;22:864–871.
   PubMed Web of Science ®Google Scholar
• Marasco G, Scaioli E, Renzulli M, et al. MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome. Am J Gastroenterol. 2016;111:767.
   PubMed Web of Science ®Google Scholar
• Han NY, Park BJ, Sung DJ, et al. Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid–enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation. Radiology. 2014;271:416–425.
   PubMed Web of Science ®Google Scholar
• Hanelin LG, Uszler JM, Sommer DG. Liver scan “hot spot” in hepatic veno-occlusive disease. Radiology. 1975;117:637–638.
   PubMed Web of Science ®Google Scholar
• Okamura H, Hayashi Y, Nakamae H, et al. Use of per rectal portal scintigraphy to detect portal hypertension in sinusoidal obstructive syndrome following unrelated cord blood transplantation. Acta Haematol. 2013;130:83–86.
   PubMed Web of Science ®Google Scholar
• Gauthe M, Bozec L, Bedossa P. Diagnosis of sinusoidal obstruction syndrome by positron emission tomography/computed tomography: report of two cases treated by defibrotide. Hepatology. 2014;60:1789–1791.
   PubMed Web of Science ®Google Scholar
• Kim H, Baek S-E, Moon J, et al. Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome. Oncotarget. 2016;7:69024–69031.
   PubMedGoogle Scholar
• Vigano L, Capussotti L, De Rosa G, et al. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg. 2013;258:731–732.
   PubMed Web of Science ®Google Scholar